Janux Therapeutics, Inc.
NASDAQ:JANXBiotechnology
Healthcare
$10.29 -1.74%
-$0.25 today
- Market cap
- $629.58M
- Beta
- 2.52
- P/E (TTM)
- -7.6
- EPS (TTM)
- -$1.83
52W Low $12.12High $35.34
Volume 0.65M
Average 1.02M
Price history
Janux Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-64.28%
Period high
$34.74
Period low
$10.29
Latest
$10.29
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 13, 2026 | Nov 13, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 | |
| 8-K | Aug 6, 2026 | Aug 6, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| 4 | Jul 31, 2026 | Jul 31, 2026 | |
| SC 13G/A | Jul 28, 2026 | Jul 28, 2026 | |
| 4 | Jul 10, 2026 | Jul 10, 2026 | |
| 8-K | Jun 23, 2026 | Jun 23, 2026 | |
| 4 | Jun 12, 2026 | Jun 12, 2026 | |
| 4 | Jun 12, 2026 | Jun 12, 2026 | |
| 4 | Jun 12, 2026 | Jun 12, 2026 | |
| 4 | Jun 12, 2026 | Jun 12, 2026 |
Competitors
Who does Janux Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about JANX's filings, answered from its disclosures.
What is the latest JANX filing?
The latest filing shown is SC 13G/A dated Nov 13, 2026.
How many recent filings does JANX have?
Intrinsic Alpha currently shows 20 recent filings for JANX.
Continue the stock analysis
Jump to another research area for this company.